Chris Pepper obtained his B.S. degree in biomedical science (1989) and his Ph.D. degree in medicine chemistry (1993) from Cardiff University. He works currently as a Reader in hematology in the School of Medicine in Cardiff University, where he runs a successful research team and heads the high-speed cell-sorting facility for the university. For the past 15 years, his research career has been focused on chronic lymphocytic leukemia (CLL). During this time, he has published over 70 Peer reviewed papers and has been serving as an Invited Speaker at numerous national and international meetings. His research team is currently addressing basic, translational, and clinical questions in CLL. These include investigations into the mechanisms that underpin the development of disease progression and drug resistance, elucidation of novel prospective biomarkers of prognosis in order to provide superior risk stratification of patient groups and the identification and validation of novel therapeutic agents. He works also as the Scientific Secretary of the UKCLL Forum, sits on the UKCLL/NCRI CLL Clinical Trials Subgroup, and is a Member of the European Research Initiative on CLL (ERIC).
Biography Updated on 10 August 2010